106 related articles for article (PubMed ID: 22683283)
1. Double-chimera proteins to enhance recruitment of endothelial cells and their progenitor cells.
Behjati M; Kazemi M; Hashemi M; Zarkesh-Esfahanai SH; Bahrami E; Hashemi-Beni B; Ahmadi R
Int J Cardiol; 2013 Aug; 167(4):1560-9. PubMed ID: 22683283
[TBL] [Abstract][Full Text] [Related]
2. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
Lim WH; Seo WW; Choe W; Kang CK; Park J; Cho HJ; Kyeong S; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2798-805. PubMed ID: 22015656
[TBL] [Abstract][Full Text] [Related]
3. Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin.
Lee JM; Choe W; Kim BK; Seo WW; Lim WH; Kang CK; Kyeong S; Eom KD; Cho HJ; Kim YC; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
Biomaterials; 2012 Dec; 33(35):8917-27. PubMed ID: 22981075
[TBL] [Abstract][Full Text] [Related]
4. Endothelial E-selectin potentiates neovascularization via endothelial progenitor cell-dependent and -independent mechanisms.
Nishiwaki Y; Yoshida M; Iwaguro H; Masuda H; Nitta N; Asahara T; Isobe M
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):512-8. PubMed ID: 17170379
[TBL] [Abstract][Full Text] [Related]
5. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice.
Foteinos G; Hu Y; Xiao Q; Metzler B; Xu Q
Circulation; 2008 Apr; 117(14):1856-63. PubMed ID: 18378610
[TBL] [Abstract][Full Text] [Related]
6. Mussel adhesive protein fused with VE-cadherin extracellular domain promotes endothelial-cell tight junctions and in vivo endothelization recovery of vascular stent.
Yang D; Yan W; Qiu J; Huang Y; Li T; Wang Y; Wang N; Durkan C; Huang J; Yin T; Wang G
J Biomed Mater Res B Appl Biomater; 2020 Jan; 108(1):94-103. PubMed ID: 30974041
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells.
Wijelath ES; Rahman S; Murray J; Patel Y; Savidge G; Sobel M
J Vasc Surg; 2004 Mar; 39(3):655-60. PubMed ID: 14981463
[TBL] [Abstract][Full Text] [Related]
8. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.
Friedl J; Turner E; Alexander HR
Int J Oncol; 2003 Sep; 23(3):611-6. PubMed ID: 12888895
[TBL] [Abstract][Full Text] [Related]
10. Human mature endothelial cells modulate peripheral blood mononuclear cell differentiation toward an endothelial phenotype.
Bellik L; Musilli C; Vinci MC; Ledda F; Parenti A
Exp Cell Res; 2008 Oct; 314(16):2965-74. PubMed ID: 18692498
[TBL] [Abstract][Full Text] [Related]
11. Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells.
Jang JH; Kim SK; Choi JE; Kim YJ; Lee HW; Kang SY; Park JS; Choi JH; Lim HY; Kim HC
Acta Pharmacol Sin; 2007 Mar; 28(3):367-74. PubMed ID: 17302999
[TBL] [Abstract][Full Text] [Related]
12. Collagen/heparin coating on titanium surface improves the biocompatibility of titanium applied as a blood-contacting biomaterial.
Chen J; Chen C; Chen Z; Chen J; Li Q; Huang N
J Biomed Mater Res A; 2010 Nov; 95(2):341-9. PubMed ID: 20623672
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium.
Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC
Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935
[TBL] [Abstract][Full Text] [Related]
14. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
[TBL] [Abstract][Full Text] [Related]
15. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
16. The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression.
Hofmann S; Grasberger H; Jung P; Bidlingmaier M; Vlotides J; Janssen OE; Landgraf R
Eur J Med Res; 2002 Apr; 7(4):171-6. PubMed ID: 12010652
[TBL] [Abstract][Full Text] [Related]
17. Behavior of Human Umbilical Vein Endothelial Cells on Titanium Surfaces Functionalized with VE-Cadherin Extracellular 1-4 Domains.
Seo HJ; Lee S; Kim JE; Jang JH
Protein Pept Lett; 2020; 27(9):895-903. PubMed ID: 32310035
[TBL] [Abstract][Full Text] [Related]
18. The effects of plasma electrolytically oxidized NiTi on in vitro endothelialization.
Huan Z; Yu H; Li H; Ruiter MS; Chang J; Apachitei I; Duszczyk J; de Vries CJM; Fratila-Apachitei LE
Colloids Surf B Biointerfaces; 2016 May; 141():365-373. PubMed ID: 26878287
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of biofunctional stents with endothelial progenitor cell specificity for vascular re-endothelialization.
Kang CK; Lim WH; Kyeong S; Choe WS; Kim HS; Jun BH; Lee YS
Colloids Surf B Biointerfaces; 2013 Feb; 102():744-51. PubMed ID: 23107953
[TBL] [Abstract][Full Text] [Related]
20. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
